Alan R. Branfman

Tumor inhibitors. 122. The maytansinoids. Isolation, structural elucidation, and chemical interrelation of novel ansa macrolides

S. Morris Kupchan, Yasuo Komoda, Alan R. Branfman et al. · The Journal of Organic Chemistry · 1977 · 131 citations

Pharmaceutical Science, Altmetric Attention Score, Pharmacotherapy +19

Tumor inhibitors. 124. Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoids

S. Morris Kupchan, Albert T. Sneden, Alan R. Branfman et al. · Journal of Medicinal Chemistry · 1978 · 88 citations

Tumor inhibitors. 96. Novel maytansinoids. Structural interrelations and requirements for antileukemic activity

S. Morris Kupchan, Yasuo Komoda, Alan R. Branfman et al. · Journal of the American Chemical Society · 1974 · 78 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +15

Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration.

M. Callahan, R Robertson, Maurice J. Arnaud et al. · Drug Metabolism and Disposition · 1982 · 63 citations

X-ray structure of tirandamycic acid p-bromophenacyl ester. Complete stereochemical assignments of tirandamycin and streptolydigin

David J. Duchamp, Alan R. Branfman, Allan C. Button et al. · Journal of the American Chemical Society · 1973 · 61 citations

Medicinal Chemistry, Pharmaceutical Science, Bioorganic Chemistry +15